You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Bulk Pharmaceutical API Sources for FLUOXYMESTERONE


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for FLUOXYMESTERONE

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Get Started Free F7751_SIGMA ⤷  Get Started Free
Amadis Chemical ⤷  Get Started Free A838701 ⤷  Get Started Free
AKos Consulting & Solutions ⤷  Get Started Free AKOS015895109 ⤷  Get Started Free
Clearsynth ⤷  Get Started Free CS-O-01553 ⤷  Get Started Free
LGC Standards ⤷  Get Started Free LGCAMP0959.00-11 ⤷  Get Started Free
LGC Standards ⤷  Get Started Free LGCFOR0959.00 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for Fluoxymesterone

Last updated: July 29, 2025

Introduction

Fluoxymesterone, a potent androgenic anabolic steroid, is actively utilized in the treatment of male hypogonadism, breast cancer, and delayed puberty. Due to its high potency and specific medical applications, the sourcing of bulk Active Pharmaceutical Ingredients (API) for fluoxymesterone involves rigorous quality standards, regulatory compliance, and a robust supply chain. This comprehensive report delineates current API suppliers, geographical manufacturing hubs, quality assurance practices, and emerging trends in sourcing fluoxymesterone.

Manufacturing and Regulatory Landscape

The production of fluoxymesterone API is predominantly centralized within countries with advanced chemical manufacturing infrastructures such as India, China, and select European nations. These regions benefit from established Good Manufacturing Practices (GMP), stringent regulatory oversight by agencies like the FDA, EMA, and international pharmacopoeias, ensuring API purity and potency.

Key API Suppliers for Fluoxymesterone

1. India

India’s pharmaceutical sector has emerged as a global hub for steroid API production, offering competitive pricing, flexible manufacturing capacities, and a broad supplier network. Prominent Indian API manufacturers include:

  • Genscript India: Known for custom synthesis, Genscript offers high-purity fluoxymesterone APIs with stringent QC protocols conforming to pharmacopeial standards. They provide APIs certified under WHO-GMP, suitable for both bulk supply and research applications.

  • Dr. Reddy’s Laboratories: A major global player, Dr. Reddy’s manufactures steroid APIs with a focus on quality assurance, adhering to international standards, and supplying APIs for regulated markets.

  • Hikal Limited: Specializing in active pharmaceutical ingredients, Hikal manufactures fluoxymesterone with competitive lead times, adhering to ISO and GMP regulations.

2. China

China remains a significant supplier of steroid APIs, including fluoxymesterone, driven by cost competitiveness and rapidly expanding chemical manufacturing capacities. Notable Chinese API producers include:

  • Zhangjiang BioPharma: Focused on steroidal APIs, Zhangjiang BioPharma provides high-grade fluoxymesterone APIs meeting international regulatory standards.

  • Qingdao Fosc Technology: Offering a broad spectrum of steroid APIs, they maintain strict quality controls suitable for both research and pharmaceutical manufacturing.

3. Europe

European suppliers tend to cater to higher-quality, regulated markets, often offering APIs with detailed compliance documentation. Key players include:

  • Synthelabo (France): Known for bio-pharmaceutical intermediates, Synthelabo provides fluoxymesterone APIs compliant with EMA standards.

  • Aventis Pharma (Germany): Although primarily a finished dosage manufacturer, they source APIs from compliant suppliers, including steroidal compounds like fluoxymesterone.

Emerging Trends in API Sourcing

  • Vertical Integration: Some pharmaceutical companies are increasingly engaging in in-house synthesis of APIs to ensure supply security and quality control, especially in high-potency steroids like fluoxymesterone.

  • Regulatory Tightening: With growing global regulatory scrutiny, suppliers are investing in advanced quality assurance systems, including comprehensive lot release testing and stability studies.

  • Sustainability Initiatives: Green chemistry practices are gaining adoption, with API manufacturers optimizing processes to reduce environmental impact, aligning with global standards.

Quality Assurance and Compliance

Given the potency and medical importance of fluoxymesterone, sourcing from compliant suppliers is critical. Suppliers typically provide:

  • Certificates of Analysis (CoA) conforming to pharmacopoeia standards (USP, EP, BP)
  • Batch traceability
  • Stability data
  • Rigorous impurity profiling

Suppliers adhering to ISO 9001, ISO 14001, and GMP certifications are preferred to ensure product consistency and regulatory acceptability.

Challenges in Sourcing

Some of the key challenges include:

  • Regulatory Barriers: Stringent regulations on anabolic steroids limit access in certain jurisdictions, requiring careful due diligence on supplier compliance.

  • Quality Variability: Variations in purity levels across suppliers demand extensive testing and validation.

  • Supply Chain Disruptions: Political, logistical, and geopolitical factors can impact the steady supply of bulk APIs.

Conclusion

The global market for fluoxymesterone API remains concentrated in India, China, and Europe, each offering unique advantages in pricing, quality, and regulatory compliance. Trusted suppliers with proven quality systems are indispensable for pharmaceutical companies aiming to maintain high standards and regulatory approvals.


Key Takeaways

  • India and China dominate the bulk API manufacturing landscape for fluoxymesterone, offering cost-effective options with varying quality assurances.
  • European suppliers emphasize regulatory compliance and premium quality, suitable for highly regulated markets.
  • Ensuring supplier certification, pharmacopoeia compliance, and thorough quality testing is crucial.
  • Strategic sourcing involves balancing cost, quality, regulatory compliance, and supply chain stability.
  • Suppliers adopting green chemistry principles and advanced QA practices provide future-ready options amidst tightening regulations.

Frequently Asked Questions (FAQs)

1. What are the primary considerations when sourcing fluoxymesterone API?
Quality assurance, compliance with GMP/regulatory standards, impurity profiles, batch traceability, and supply chain reliability.

2. Can I source fluoxymesterone API from multiple suppliers?
Yes, diversifying suppliers mitigates risks related to supply disruptions and ensures competitive pricing; however, rigorous verification of each supplier’s quality systems is essential.

3. Are there regulatory restrictions on importing fluoxymesterone API?
Yes, as a controlled substance or potent steroid, regulations vary by country, with some requiring special licensing, registration, and compliance documentation.

4. Which regions offer the highest quality APIs for pharmaceutical manufacturing?
Europe typically provides APIs with the strictest regulatory oversight, while India and China offer cost-competitive options with increasing compliance standards.

5. What are future trends impacting API sourcing for fluoxymesterone?
Enhanced regulatory scrutiny, adoption of green chemistry, vertical integration by pharmaceutical firms, and digital traceability solutions are shaping future sourcing strategies.


References

[1] Pharmaceuticals and medical device manufacturing guidelines, WHO.
[2] Global API Market Report, IQVIA, 2022.
[3] Regulatory Framework for Steroid APIs, EMA.
[4] Supply Chain Insights, Asian Chemical News, 2022.
[5] Green Chemistry in API Manufacturing, Green Chemistry Journal, 2021.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.